Literature DB >> 20014062

Photophobia in essential blepharospasm--a positron emission tomographic study.

Hirofumi Emoto1, Yukihisa Suzuki, Masato Wakakura, Chiharu Horie, Motohiro Kiyosawa, Manabu Mochizuki, Keiichi Kawasaki, Keiichi Oda, Kiichi Ishiwata, Kenji Ishii.   

Abstract

To localize regional alterations in cerebral glucose metabolism in essential blepharospasm (EB) patients with photophobia. We have studied 22 EB patients by performing positron emission tomography and [(18)F]-fluorodeoxyglucose analysis. The patients were classified into two subgroups, namely, EB with photophobia (P group) and EB without photophobia (NP group), and compared with a healthy control group (n = 44). There were no significant differences between the two patient groups with respect to the severity of motor symptoms or the duration for which the condition persisted. The FDG-PET images were analyzed using the statistical parametric mapping software. As compared to the control group, the P group exhibited significant hypermetabolism in the thalamus (P = 0.002), while the NP group exhibited significant hypometabolism in the dorsal midbrain, especially, in the superior colliculus (P = 0.005). The P group exhibited significant hypermetabolism in the thalamus and the dorsal midbrain as compared to the NP group (P < 0.001). These findings suggest that photophobia in EB patients may be associated with abnormal hyperactivity in the thalamus. Either hyperactivity of the thalamus or hypoactivity of the superior colliculus, or both may be associated with excessive blinking in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20014062     DOI: 10.1002/mds.22916

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  20 in total

Review 1.  Secondary blepharospasm associated with structural lesions of the brain.

Authors:  M A Khooshnoodi; S A Factor; H A Jinnah
Journal:  J Neurol Sci       Date:  2013-06-06       Impact factor: 3.181

2.  Altered regional spontaneous neuronal activity in blepharospasm: a resting state fMRI study.

Authors:  Jing Yang; ChunYan Luo; Wei Song; Qin Chen; Ke Chen; XuePing Chen; XiaoQi Huang; QiYong Gong; HuiFang Shang
Journal:  J Neurol       Date:  2013-07-31       Impact factor: 4.849

Review 3.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

Review 4.  Shedding light on photophobia.

Authors:  Kathleen B Digre; K C Brennan
Journal:  J Neuroophthalmol       Date:  2012-03       Impact factor: 3.042

Review 5.  Sensory aspects of movement disorders.

Authors:  Neepa Patel; Joseph Jankovic; Mark Hallett
Journal:  Lancet Neurol       Date:  2014-01       Impact factor: 44.182

Review 6.  Photophobia in primary headaches.

Authors:  Heather L Rossi; Ana Recober
Journal:  Headache       Date:  2015-03-19       Impact factor: 5.887

7.  Direct optic nerve pulvinar connections defined by diffusion MR tractography in humans: implications for photophobia.

Authors:  Nasim Maleki; Lino Becerra; Jaymin Upadhyay; Rami Burstein; David Borsook
Journal:  Hum Brain Mapp       Date:  2011-02-17       Impact factor: 5.038

8.  Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB.

Authors:  Yoshihiko Isshiki; Hiroto Ishikawa; Osamu Mimura
Journal:  Jpn J Ophthalmol       Date:  2016-08-08       Impact factor: 2.447

Review 9.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

10.  Blepharospasm in Japan: A Clinical Observational Study From a Large Referral Hospital in Tokyo.

Authors:  M Wakakura; A Yamagami; M Iwasa
Journal:  Neuroophthalmology       Date:  2018-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.